Yellow Pages Listings Sample Clauses

Yellow Pages Listings. Unless otherwise requested by a subscriber to local business telephone services, the Directory Publisher will provide without charge in the yellow pages of the Directories under a classification in the approved heading structure best describing the subscriber's business one light-face standard listing representing the primary listing of each subscriber to business telephone service as accepted by the Telephone Company for publication in the white pages of the Directories where applicable. Nothing in this Agreement (including Sections 1.3(a), 4.1(a)(iv) and 5.6) shall constitute an obligation for the Directory Publisher to produce white pages; provided that, should the Directory Publisher cease publication of white pages in any market in which the Telephone Company offers local service, the Directory Publisher will provide twelve months' prior written notice to the Telephone Company.
AutoNDA by SimpleDocs
Yellow Pages Listings. Unless otherwise requested by a subscriber to local business telephone services, the Directory Publisher will provide without charge in the yellow pages of the Directories under a classification in the approved heading structure best describing the subscriber's business one light-face standard listing representing the primary listing of each subscriber to business telephone service as accepted by the Telephone Company for publication in the white pages of the Directories where applicable. Nothing herein shall constitute an obligation for the Directory Publisher to produce white pages; PROVIDED that, should the Directory Publisher cease publication of white pages in any market in which the Telephone Company offers local service, the Directory Publisher will provide twelve months' prior written notice to the Telephone Company.

Related to Yellow Pages Listings

  • PORTAL At the Closing Time, the Securities shall have been designated for trading on PORTAL.

  • Directory The bulletin board or directory of the Building will be provided exclusively for the display of the name and location of tenants and Landlord reserves the right to exclude any other names therefrom.

  • Listings The listing of any name other than that of Tenant, whether on the doors of the Premises or the Building directory, or otherwise, shall not operate to vest any right or interest in this Lease or in the Premises, nor shall it be deemed to be the consent of Landlord to any assignment or transfer of this Lease or to any sublease of the Premises or to the use or occupancy thereof by others. Any such listing shall constitute a privilege extended by Landlord, revocable at Landlord's will by notice to Tenant.

  • Patent Listings Licensee shall have the right and responsibility to make all filings with Regulatory Authorities in the Territory with respect to the AstraZeneca Patents, including as required or allowed (i) in the United States, in the FDA’s Orange Book and (ii) in the European Union, under the national implementations of Article 10.1(a)(iii) of Directive 2001/EC/83 or other international equivalents; provided that Licensee shall consult with AstraZeneca to determine the course of action with respect to such filings.

  • Website To the knowledge of the Company, none of the information on (or hyperlinked from) the Company’s website at xxx.xxxxxx.xxx includes or constitutes a “free writing prospectus” as defined in Rule 405 under the Securities Act.

  • Websites Distributor shall utilize the Company's proprietary Internet site, and may link to "TXXXXXXXXXXXXXXX.XXX" as a source for new customers and related matters.

  • Internet Distributor shall follow the Company's written -------- instructions with respect to each of the following: (i) use of any information about the Company or the Products available on the Internet; (ii) linking of any site on the Internet to any other site on the Internet established, operated or sponsored by the Company; and (iii) use of any of the Trademarks or Promotional Materials on any site on the Internet. Distributor acknowledges that it shall cease the activities described in (i), (ii) and/or (iii) above, if so instructed by the Company. In no event shall Distributor establish, operate, sponsor or contribute content to any site on the Internet which incorporates the word "verichip" as its URL address or any part of such address.

  • DTC DIRECT REGISTRATION SYSTEM AND PROFILE MODIFICATION SYSTEM (a) Notwithstanding the provisions of Section 2.4 of the Deposit Agreement, the parties acknowledge that DTC’s Direct Registration System (“DRS”) and Profile Modification System (“Profile”) apply to the American Depositary Shares upon acceptance thereof to DRS by DTC. DRS is the system administered by DTC that facilitates interchange between registered holding of uncertificated securities and holding of security entitlements in those securities through DTC and a DTC participant. Profile is a required feature of DRS that allows a DTC participant, claiming to act on behalf of an Owner of American Depositary Shares, to direct the Depositary to register a transfer of those American Depositary Shares to DTC or its nominee and to deliver those American Depositary Shares to the DTC account of that DTC participant without receipt by the Depositary of prior authorization from the Owner to register that transfer.

  • Advertising Materials As an independent contractor, Representative has the full right to exercise his or her independent judgment in determining whether to advertise. Any advertising undertaken by Representative will be at his or her expense. However, to comply with applicable statutes, rules and regulations, Representative will submit to the Company for review all advertising or sales literature, as defined by the FINRA Rules, that Representative intends to use and obtain prior written approval of the proposed use of the literature by the Company.

  • Advertising Materials; Filed Documents (a) Advertising and sales literature with respect to any Fund prepared by the Company or its agents for use in marketing its Contracts will be submitted to that Fund or its designee for review before such material is submitted to any regulatory body for review. No such material shall be used if the Fund or its designee reasonably objects to such use in writing, transmitted by facsimile within two business days after receipt of such material.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!